The success of molecular imaging with positron‐emission tomography (PET) depends on
the availability of selective molecular probes labeled with positron‐emitters, such asfluorine …

2-deoxy-2-[18F] fluoro-d-glucose (18FDG) was developed in 1976 in a collaboration
between scientists at the National Institutes of Health, the University of Pennsylvania, and …

INTRODUCTION: A novel [18F]-radiolabelled phenoxyanilide,[18F]-FEPPA, has been
synthesized and evaluated, in vitro and ex vivo, as a potential positron emission tomography …

A novel, efficient, time-saving and reliable radiolabeling procedure via nucleophilic
substitution with [18F] fluoride is described. Different radiolabeled aliphatic and aromatic …

BACKGROUND: Serotonin 5-HT2A receptors play an important role in the regulation of
many functions that are disturbed in patients with major depressive disorder. Postmortem …

Data for the production of fluorine-18 (t 1/2= 109.6 min; β+= 100%) are reviewed. The
experience of some well-established European centres for positron emission tomography …

Positron emission tomography (PET) is a non-invasive imaging technology which provides a
unique window on the physiology and function of living organisms. It uses short-lived …

This paper provides a brief review of the radiochemistry of radiopharmaceuticals used in
positron emission tomography (PET). It includes some history of PET, the basic formation of …

Many experimental and established tracers make fluorine-18 the most widely used
radionuclide in positron emission tomography with an increasing demand for new or simpler …

[F-18] 16α-Fluoroestradiol (FES) has been shown to be a tracer of estrogen receptor content
in breast tumors; however, quantitative analysis of FES images is complicated by the rapid …